Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma
- 1 January 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10) , 1692-1695
- https://doi.org/10.1016/0959-8049(92)90070-i
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Immunohistochemistry of neuron-specific enolase in neurons of the medulla oblongata from human autopsiesActa Histochemica, 1998
- Neuron specific enolase (NSE) in serum of patients with malignant melanomaCancer Letters, 1990
- Neuron-Specific Enolase-- A Serum marker for Malignanat MelanomaJNCI Journal of the National Cancer Institute, 1989
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Regression analyses of prognostic factors in metastatic malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.Journal of Clinical Pathology, 1986
- Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.Journal of Clinical Pathology, 1986
- Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastomaHistopathology, 1982
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958